Nova R Wealth Inc. cut its stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 2.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 313,846 shares of the company’s stock after selling 6,396 shares during the quarter. BlackRock Health Sciences Trust comprises about 6.0% of Nova R Wealth Inc.’s investment portfolio, making the stock its 3rd largest position. Nova R Wealth Inc.’s holdings in BlackRock Health Sciences Trust were worth $12,127,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also made changes to their positions in the company. Ameriflex Group Inc. purchased a new stake in BlackRock Health Sciences Trust during the fourth quarter worth about $41,000. Comerica Bank lifted its position in shares of BlackRock Health Sciences Trust by 13.1% during the 4th quarter. Comerica Bank now owns 4,454 shares of the company’s stock valued at $169,000 after acquiring an additional 517 shares during the period. Oppenheimer & Co. Inc. boosted its stake in shares of BlackRock Health Sciences Trust by 8.4% during the 1st quarter. Oppenheimer & Co. Inc. now owns 6,295 shares of the company’s stock worth $243,000 after acquiring an additional 486 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of BlackRock Health Sciences Trust by 6.1% during the 4th quarter. First Trust Advisors LP now owns 6,856 shares of the company’s stock worth $260,000 after acquiring an additional 393 shares in the last quarter. Finally, HBK Sorce Advisory LLC grew its holdings in shares of BlackRock Health Sciences Trust by 14.8% in the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after acquiring an additional 1,057 shares during the period.
BlackRock Health Sciences Trust Stock Up 0.5%
Shares of BME stock opened at $36.20 on Thursday. The stock has a fifty day moving average price of $36.19 and a 200 day moving average price of $37.95. BlackRock Health Sciences Trust has a 1 year low of $34.18 and a 1 year high of $42.64.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Want to Profit on the Downtrend? Downtrends, Explained.
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- Manufacturing Stocks Investing
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Stock Market Upgrades: What Are They?
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.